Browsing Category
Healthcare Industry News
2470 posts
Lactose in medicine: uses, varieties, and why it is essential for drug formulation
Discover how lactose is used in pharmaceuticals, from tablet fillers to inhalers and infant formulas, with details on its types and medical applications.
Ginseng chemical composition and proven health benefits: how it works in the human body
Discover how ginseng works, its chemical compounds, and its proven benefits for immunity, fatigue, diabetes, hormonal balance, and healthy aging.
Jalbrahmi (Centella asiatica): Chemical constituents, synonyms and therapeutic uses explained
Learn how Jalbrahmi (Centella asiatica) works, its chemical constituents, synonyms across languages, and how it benefits brain health and skin healing.
FCPT acquires six Novant Health urgent care properties in $12m deal as healthcare real estate gains momentum
FCPT’s $12M Novant Health urgent care acquisition highlights its strategic shift toward defensive healthcare real estate, boosting investor confidence.
Why Neogen’s 3m food safety integration failure triggered a class action and reshaped investor sentiment in diagnostics
Neogen faces a class action over alleged misstatements in its 3M food safety division integration, raising critical questions about governance and M&A transparency.
Can AI-driven blood diagnostics redefine how consumers access personalized nutrition in 2025?
AI-powered blood diagnostics platforms like InsideTracker and Thorne HealthTech are transforming how consumers personalize nutrition. Explore what’s next.
What does BD gain from the $4bn cash windfall—and how fast will buybacks follow the spin?
BD’s $4B cash windfall from the Waters merger could reshape its capital strategy. Will buybacks come first, or will growth investments take priority?
Can Concord Healthcare’s proton AI model become China’s blueprint for precision oncology scaling?
Can Concord Healthcare’s proton AI model reshape cancer care in China? Learn how this precision oncology tool could become the country’s blueprint for scaling.
Lumos Diagnostics shares surge 155% on ASX after $317m U.S. FebriDx deal with PHASE Scientific
Lumos Diagnostics surges 155% after securing a $487M U.S. FebriDx deal with PHASE Scientific. Find out what this means for investors in 2025.
Can Waters bring LC-MS into routine diagnostics with BD’s hospital channel access?
Can Waters bring LC-MS to hospitals through its $17.5B BD merger? Find out how this deal could redefine clinical mass spectrometry adoption in diagnostics.